Issuer Information

EDGAR: Contact Information
  • Name:
    Lion Biotechnologies, Inc.
  • Address:
    112 WEST 34TH STREET
    17TH FLOOR

    NEW YORK, NEW YORK 10120
  • Phone:
    212-946-4826
EDGAR: Other Information
  • Jurisdiction:
    NEVADA
  • Entity Type:
    Corporation
  • Incorporated:
    Over 5 years ago
  • Previous Names:
    FREIGHT MANAGEMENT CORP
    Genesis Biopharma, Inc

These are those Form D offerings for which this issuer is designated as the primary issuer.

EFDID/AccessionDetailsFed. ExemptionsNotices
166839: 0001250853-16-000157
First Sale: 2016-06-02
Security Type(s): Equity
Offer Amount: $100,000,000
Amount Sold: $100,000,000
06b No Notices in EFD for this offering.
84323: 0001250853-13-000113
First Sale: 2013-11-05
Security Type(s): Equity
Offer Amount: $23,290,600
Amount Sold: $23,290,600
06b No Notices in EFD for this offering.
75486: 0001513160-13-000035
First Sale: 2013-05-22
Security Type(s): Equity
Offer Amount: $1,350,000
Amount Sold: $1,350,000
06 No Notices in EFD for this offering.
41609: 0001144204-11-044671
First Sale: 2011-07-27
Security Type(s): Debt
Offer Amount: $5,000,000
Amount Sold: $5,000,000
06 No Notices in EFD for this offering.
36596: 0001144204-11-025734
First Sale: 2011-04-17
Security Type(s): Equity
Offer Amount: $1,000,000
Amount Sold: $500,000
Remaining: $500,000
06 No Notices in EFD for this offering.
31288: 0001483806-11-000003
First Sale: 2010-12-28
Security Type(s): Equity
Offer Amount: $640,000
Amount Sold: $640,000
06 No Notices in EFD for this offering.
26764: 0001483806-10-000007
First Sale: 2010-10-22
Security Type(s): Equity
Offer Amount: $250,000
Amount Sold: $250,000
06 No Notices in EFD for this offering.
24749: 0001483806-10-000005
First Sale: 2010-09-17
Security Type(s): Equity
Offer Amount: $500,000
Amount Sold: $500,000
06 No Notices in EFD for this offering.

These Form D offerings are those which this issuer is defined as an issuer for the offering, but are not the primary issuer.

This issuer currently is not a non-primary issuer for any Form D offerings.